Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

1 Beaten-Down Stock That's Still Not Worth Buying

TheMotleyFool

0 0

1 Beaten-Down Stock That's Still Not Worth Buying: https://g.foolcdn.com/editorial/images/767745/doctor-vaccinating-a-patient.jpg

Investing basics tell us to "buy low" and invest in a stock when there looks to be significant upside potential. That can often be after a company gets put through the wringer and the stock declines substantially. However, sometimes it's not worth investing in a company no matter how much its shares fall.

Case in point: Novavax (NASDAQ: NVAX) is a biotech stock down by 97% over the past three years, yet the stock still doesn't look attractive. Read on to find out why.